A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is
Comparison of short-term DAPT and long-term DAPT on the prognosis of PCI patients: a meta-analysis of randomized controlled trials
Background This article aimed to evaluate the safety and effectiveness of short-term (3–6 months) dual antiplatelet therapy (DAPT) compared to long-term (12 months) DAPT. Methods We searched PubMed, Embase, Cochrane Library, and Web of Science for all the randomized controlled trials which compared the different durations of DAPT after the percutaneous coronary intervention within ten years before January 2021. The safety endpoint included major bleeding and any bleeding. The efficacy endpointsdoi:10.21203/rs.3.rs-1616146/v1 fatcat:efdyl7ocvjffjbstf5hlbchdma